Portal de Periódicos da CAPES

A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism

2002; Taylor & Francis; Volume: 22; Issue: 24 Linguagem: Inglês

10.1128/mcb.22.24.8601-8611.2002

1098-5549

Zach Serber, Helen C. Lai, Annie Yang, Horng D. Ou, Martina Sigal, Alexander E. Kelly, Beatrice Darimont, Pascal H. G. Duijf, Hans van Bokhoven, Frank McKeon, Volker Dötsch,

Molecular Biology Techniques and Applications

The human genome is far smaller than originally estimated, and one explanation is that alternative splicing creates greater proteomic complexity than a simple count of open reading frames would suggest. The p53 homologue p63, for example, is a tetrameric transcription factor implicated in epithelial development and expressed as at least six isoforms with widely differing transactivation potential. In particular, p63alpha isoforms contain a 27-kDa C-terminal region that drastically reduces their activity and is of clear biological importance, since patients with deletions in this C terminus have phenotypes very similar to patients with mutations in the DNA-binding domain. We have identified a novel domain within this C terminus that is necessary and sufficient for transcriptional inhibition and which acts by binding to a region in the N-terminal transactivation domain of p63 homologous to the MDM2 binding site in p53. Based on this mechanism, we provide a model that explains the transactivation potential of homo- and heterotetramers composed of different p63 isoforms and their effect on p53.